Kamalesh C. Dey

Dr. Kamalesh C. Dey

University of Bedfordshire, Luton, UK
orcid

Research Focus & Metrics

Academic Career Length

57Years (1970-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Kamalesh C. DeyKamalesh C. Dey
Kamalesh C. Dey
JZJulia Kirstey Zakrzewski-Fruer
Julia Kirstey Zakrzewski-Fruer
LSLindsey R. Smith
Lindsey R. Smith
RJRebecca L. Jones
Rebecca L. Jones
DBDaniel Bailey
Daniel Bailey
This study aimed to systematically review total daily sedentary time in South Asian adults. Seven electronic databases were searched, identifying relevant articles published in peer-reviewed journals between March 1990 and March 2021. The study was designed in accordance with PRISMA guidelines. Prospective or cross-sectional design studies reporting total daily sedentary time in South Asian adults (aged ≥18 years), reported in English, were included. Study quality and risk of bias were assessed, and the weighted mean total daily sedentary time was calculated. Fourteen full texts were included in this systematic review from studies that were conducted in Bangladesh, India, Norway, Singapore, and the United Kingdom. Pooled sedentary time across all studies was 424 ± 8 min/day. Sedentary time was measured using self-report questionnaires in seven studies, with a weighted mean daily sedentary time of 416 ± 19 min/day. Eight studies used accelerometers and inclinometers with a weighted mean sedentary time of 527 ± 11 min/day. South Asian adults spend a large proportion of their time being sedentary, especially when recorded using objective measures (~9 h/day). These findings suggest that South Asians are an important target population for public health efforts to reduced sedentary time, and researchers and practitioners should seek to standardise and carefully consider the tools used when measuring sedentary time in this population.

 in Nusantara Bioscience
Verified
Journal Article
Open access
WCWenpu Chen
Wenpu Chen
XLXiang Li
Xiang Li
RRRamim Tanver Rahman
Ramim Tanver Rahman
NANabil Qaid M. Al-Hajj
Nabil Qaid M. Al-Hajj
Kamalesh C. DeyKamalesh C. Dey
Kamalesh C. Dey
SRSaleh Muhammed Raqib
Saleh Muhammed Raqib
Chen W, Li X, Rahman MRT, Al-Hajj NQM, Dey KC, Raqib SM. 2014. Emulsification properties of soy bean protein. Nusantara Bioscience 6: 196-202. Emulsion stability and emulsifying ability are two important factors in food industry. Soy protein has the great of interest because of its amphilic structure. β-Conglycinnin and glycinin are main components in soy protein which can be used as emulsifiers in food processing. However, due to its size and molecular weight, the emulsifying ability of soy protein is limited. By chemical, physical and enzymatic modification, the emulsifying ability of soy protein can be improved. The addition of polysaccharides in emulsion is common. The interaction of polysaccharides and proteins are being discussed in this review. In some complex food emulsion, the function of soy protein molecules and emulsifier at the interface need to be investigated in the future study.

11 November 2023 in European Journal of Applied Physiology
Verified
Journal Article
Open access
PDF file
Kamalesh C. DeyKamalesh C. Dey
Kamalesh C. Dey
JZJulia Kirstey Zakrzewski-Fruer
Julia Kirstey Zakrzewski-Fruer
LSLindsey R. Smith
Lindsey R. Smith
Rebecca Louise JonesRebecca Louise Jones
Rebecca Louise Jones
DBDaniel Bailey
Daniel Bailey
Purpose: This study examined the acute effects of interrupting sitting with light-intensity walking on postprandial cardiometabolic risk markers in South Asian adults. Methods: South Asians with overweight/obesity (n = 19; body mass index [BMI] > 23 kg·m−2) and normal-weight (n = 8; BMI 18.0–22.9 kg·m−2) aged 48.8 ± 5.6 years completed two, 5-h conditions: (1) prolonged sitting (SIT), and (2) interrupted sitting with 5-min bouts of light-intensity walking every 30-min (INT-SIT). Blood samples and resting expired air samples were collected throughout each condition. Statistical analyses were completed using linear mixed models. Results: In participants with overweight/obesity, postprandial glucose, triglycerides (TAG) and metabolic load index (MLI) over time were lower, whereas resting substrate utilisation and resting energy expenditure (REE) were higher, in INT-SIT than SIT (all p ≤ 0.05). Compared with SIT (0.18 [95% CI 0.13, 0.22] kcal.min−1), INT-SIT (0.23 [95% CI 0.18, 0.27] kcal.min−1) increased postprandial REE iAUC in participants with overweight/obesity (p = 0.04, d = 0.51). Postprandial TAG concentrations over time were lower in INT-SIT versus SIT (p = 0.01, d = 30) in normal-weight participants, with no differences in any other outcomes for this sample group. Conclusion: These findings suggest that interrupting sitting with 5-min bouts of light walking every 30-min acutely attenuates cardiometabolic risk markers among South Asians living with overweight/obesity, whereas limited effects may be seen in individuals with normal-weight.

4 December 2023 in medRxiv
Verified
Preprint
Open access
PDF file
ACAnnabelle Coleman
Annabelle Coleman
ATAlexiane Touzé
Alexiane Touzé
MFMena Farag
Mena Farag
MPMarta Pengo
Marta Pengo
MMMichael J Murphy
Michael J Murphy
LBLauren M Byrne
Lauren M Byrne
Promising blood-based biomarkers of neuropathology have emerged with potential for therapeutic development and disease monitoring. However, these tools will require specialist tertiary services for integration into clinical management. Remote sampling for biomarker assessment could ease the burden of in-person clinical visits for such tests and allow for frequent sampling. Here we evaluated a capillary finger-prick collection for remote quantification of blood neurofilament light (NfL), a common blood-based biomarker evident in various neurological disorders, and other exploratory markers of neuronal injury and neuroinflammation (GFAP, tau). Matched samples from venepuncture and finger-prick were collected and processed into plasma and/or serum to directly compare NfL levels across four different neurological conditions (HD, MS, ALS, PD). Two delayed processing conditions were compared, three- and seven-day delay, simulating ambient shipment. Capillary NfL and GFAP concentrations were equivalent to those in venous blood serum and plasma. Only NfL remained stable after seven-day processing delay. Capillary NfL replicated disease group differences displayed in venous blood. This data supports our finger-prick method for remote collection and quantification of NfL. With the widespread applications for NfL across the spectrum of neurological disorders, this has the potential to transform disease monitoring, prognosis, and therapeutic development within clinical practice and research. Graphical Figure 1

5 August 2025 in European Journal of Applied Physiology
Verified
Journal Article
Open access
PDF file
Kamalesh C. DeyKamalesh C. Dey
Kamalesh C. Dey
JZJulia Kirstey Zakrzewski-Fruer
Julia Kirstey Zakrzewski-Fruer
LSLindsey R. Smith
Lindsey R. Smith
Rebecca Louise JonesRebecca Louise Jones
Rebecca Louise Jones
BMBen David Maylor
Ben David Maylor
DBDaniel Bailey
Daniel Bailey
Background: Controlled laboratory studies have demonstrated that breaking up sitting can reduce postprandial glucose in South Asian adults. This study examined the effects of substituting sitting with standing and walking on interstitial glucose in South Asian individuals under free-living conditions. Methods: South Asian adults ( n = 14 [50% male]; body mass index 26.5 ± 0.8 kg·m −2 ) aged 41 ± 3 years completed two, 4-day regimens in a counter-balanced order: (1) SIT (restrict walking and standing to ≤ 1 h/day each) and (2) SITless (substitute ≥ 5 h/day of sitting with ≥ 3 h of standing and ≥ 2 h of walking, and interrupt sitting every 30 min). Interstitial glucose was measured using Flash glucose monitoring. Sitting and physical activity were measured with the activPAL3. Outcomes were compared between regimens using linear mixed models. Results: Interstitial glucose net incremental area under the curve (iAUC) for waking hours was lower by − 9.2 mmol L −1 ·16 h −1 (95% Confidence Interval [CI]: − 18.1, − 0.3) in SITless than SIT ( p = 0.04), while lunch postprandial glucose iAUC was significantly lower by -1.0 mmol L −1. 2 h −1 (95% CI − 1.8, 0.2) in SITless ( p = 0.02). There were no significant differences in other 24 h or 16 h glucose metrics ( p ≥ 0.06). Compared to SIT, sitting was lower by − 3.6 h/day (95% CI − 4.9, − 2.3) in SITless ( p < 0.01). Standing and stepping time were higher by 1.9 h/day (95% CI 0.6, 3.2) and 1.6 h/day (95% CI 1.2, 2.1) in SITless ( p ≤ 0.01). Conclusions: Substituting sitting with standing and walking under free-living conditions can be used to effectively attenuate glycaemia during waking hours, but not across 24 h, in South Asian adults. Clinical trial registration: NCT04645875..

11 October 2024 in medRxiv
Verified
Preprint
Open access
PDF file
VAViktoria Azoidou
Viktoria Azoidou
KRKira Rowsell
Kira Rowsell
ECEllen Camboe
Ellen Camboe
Kamalesh C. DeyKamalesh C. Dey
Kamalesh C. Dey
AZAlexandra Zirra
Alexandra Zirra
CSCristina Simonet
Cristina Simonet
Introduction Current treatments for patients with Parkinson’s disease (PwP) can fail to address gait disturbance and falls, which in turn affect quality of life (QoL). The CUE1 device delivers cueing with vibrotactile stimulation showing potential to alleviate motor symptoms and reduce falls based on preliminary user testing results. Objectives To evaluate the feasibility, safety, and tolerability of CUE1 and its effect on motor and non-motor symptoms in PwP. Methods PwP used the CUE1 for 9-weeks and were assessed at week 0, 3, 6, and 9 on MDS-UPDRS Part-III, Timed Up and Go (TUG), TUG with dual task (DT), Functional Gait Assessment (FGA), and Bradykinesia Akinesia Incoordination (BRAIN) test. Patients reported outcomes through MDS-UPDRS Part-I, -II, and -IV and Pittsburgh Sleep Quality Index (PSQI). Results Ten PwP (5 females, age range: 46-80; disease duration: 3-9 years) completed the CUE1 intervention with 100% compliance and no adverse events. CUE1 comfort and usability were rated highly (80%). Immediate CUE1 effect was observed on MDS-UPDRS- III(45.40±12.22 vs 39.60±11.74, p=0.008), TUG(11.53±1.92 vs 11.08±1.94, p=0.022), TUG DT(18.57±5.75 vs 17.61±6.28, p=0.037) and FGA(16.40±3.86 vs 18.60±3.92, p=0.007). Cumulative effect was noted on MDS-UPDRS-III(45.40±12.22 vs 27.80±12.32, p=0.005), FGA(18.60±3.92 vs 23.10± 2.85, p<0.001), TUG DT(18.57±5.75 vs 13.58±7.05, p=0.031), BRAIN kinesia (45.10±14.39 vs 42.10±12.74, p<0.001) and incoordination (24331.09±38017.46 vs 14059.91± 9030.96, p=0.016) scores, PSQI(10.10±4.95 vs 6.90±3.81, p=0.002), MDS-UPDRS-I(18.60±6.75 vs 12.20±3.68, p=0.011), MDS-UPDRS- II(17.30±7.29 vs 11.90±8.67, p=0.002), and MDS-UPDRS-IV(7.50±3.75 vs 3.40±2.95, p=0.003). Conclusion In this unblinded, feasibility study, cueing with the CUE1 appeared to be a feasible and safe intervention for PwP improving motor and non-motor features. Background and Objectives This study looked at the use of a device called CUE1, which provides rhythmic pulsing vibration to help reduce movement and non-movement symptoms in people with Parkinson’s disease (PwP). Even with current treatments, issues with walking and falling still affect the quality of life for many patients. The goal of this study was to see if CUE1 could be a helpful, safe, and easy-to-use tool for improving movement symptoms, like walking and risk of falling, as well as non-movement symptoms, like sleep. Procedures and Results Ten people with Parkinson’s (5 women, aged 46-80) who had Parkinson’s for 3-9 years used the CUE1 device for 9 weeks. Everyone finished the study, using the device regularly with no negative side effects. The device was rated 80% for comfort and ease of use. Significant improvements were seen in movement abilities (using the MDS-UPDRS-III test), walking speed, and fall risk. Over the 9 weeks, participants showed further progress in movement, balance, and coordination. Non-movement symptoms, like sleep, also improved. Conclusions The CUE1 device, which provides gentle vibrations to assist with movement, was found to be safe, easy to use, and effective. It improved both movement-related symptoms like balance and walking, as well as non-movement symptoms like sleep. This makes it a promising new treatment option for people with Parkinson’s.